Arkolith/Insider Trading/APVO/Form 4

Abdun-Nabi Daniel

DirectorAptevo Therapeutics Inc. (APVO) · full profile →Form 4 · filed Jun 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2024Option exercise(M)81——277
Jun 1, 2024Option exercise(M)7——196

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 2, 2024Option exercise(M)81—$00
Jun 1, 2024Option exercise(M)7—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-068070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML